Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Entrada Therapeutics | TRDA | Aug 30, 2024 | 17.70 | +1.14 |
Entravision Communications | EVC | Aug 30, 2024 | 2.08 | +4.00 |
Envela | ELA | Aug 30, 2024 | 4.91 | +1.45 |
Enveric Biosciences | ENVB | Aug 30, 2024 | 0.51 | +1.26 |
Envestnet | ENV | Aug 30, 2024 | 62.75 | +0.27 |
Enviri | NVRI | Aug 30, 2024 | 11.95 | +3.55 |
Environmental Svcs ETF Market Vectors | EVX | Aug 30, 2024 | 180.28 | +1.08 |
Envirotech Vehicles | EVTV | Aug 30, 2024 | 1.86 | -1.33 |
Envista | NVST | Aug 30, 2024 | 18.26 | -0.76 |
Enviva | EVA | Aug 30, 2024 | 0.53 | +6.90 |
Envoy Medical A | COCH | Aug 30, 2024 | 3.02 | +1.00 |
enVVeno Medical | NVNO | Aug 30, 2024 | 5.26 | -0.75 |
Enzo Biochem | ENZ | Aug 30, 2024 | 1.14 | -0.87 |
EOG Resources | EOG | Aug 30, 2024 | 128.82 | -0.89 |
Eos Energy Enterprises | EOSE | Aug 30, 2024 | 2.67 | -3.61 |
EPAM Systems | EPAM | Aug 30, 2024 | 200.76 | -0.24 |
EpicQuest Eduaction Group | EEIQ | Aug 30, 2024 | 0.72 | 0.00 |
ePlus | PLUS | Aug 30, 2024 | 95.96 | +1.23 |
EPR Properties | EPR | Aug 30, 2024 | 47.47 | +0.72 |
EPR Properties Pref C | EPR-C | Aug 30, 2024 | 21.93 | +1.53 |
EPR Properties Pref E | EPR-E | Aug 30, 2024 | 29.70 | +2.41 |
EPR Properties Pref G | EPR-G | Aug 30, 2024 | 23.01 | +4.56 |
Epsilon Energy | EPSN | Aug 30, 2024 | 5.43 | -1.09 |
EQT | EQT | Aug 30, 2024 | 33.51 | 0.00 |
Equifax | EFX | Aug 30, 2024 | 307.13 | +1.09 |
Equillium | EQ | Aug 30, 2024 | 1.07 | -0.93 |
Equinix | EQIX | Aug 30, 2024 | 834.36 | +1.91 |
Equinor ADR | EQNR | Aug 30, 2024 | 26.89 | -1.07 |
Equinox Gold | EQX | Aug 30, 2024 | 5.67 | -1.39 |
Equitable A Pref | EQH-A | Aug 30, 2024 | 23.02 | -0.73 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.